2010 CME Full-Day Courses:

Atlanta, GA
Tuesday, March 2, 2010
Hyatt Regency Atlanta
Preliminary Agenda
Brochure and Registration Form
Syllabus Book
Dr Deek's Handouts
Dr Lennox's Handouts
Keyslides

Los Angeles, CA
Wednesday, March 10, 2010
Reinassance Hollywood Hotel
Preliminary Agenda
Brochure and Registration Form
Syllabus Book
Keyslides

New York, NY (Spring)
Monday, March 22, 2010
Grand Hyatt New York
Preliminary Agenda
Brochure and Registration Form
Syllabus Book
Keyslides

Chicago, IL
Monday, April 19, 2010
Marriott Chicago Downtown
Preliminary Agenda
Brochure and Registration Form
Syllabus Book
Keyslides

San Francisco, CA
Monday, May 17, 2010
Grand Hyatt San Francisco
Preliminary Agenda
Brochure and Registration Form
Syllabus Book
Keyslides

Washington, DC
Thursday, June 17, 2010
Capital Hilton
Preliminary Agenda
Brochure and Registration Form
Syllabus Book
Keyslides

New York, NY (Fall)
Tuesday, October 5, 2010
New York Marriott Marquis
Registration Form
Preliminary Agenda





Click here to view past courses



2010 Annual Clinical Conference
for the Ryan White HIV/AIDS Program
Washington, DC
August 23-25, 2010
Marriott Wardman Park Hotel
Click here for more information


2009 Annual Clinical Conference
for the Ryan White HIV/AIDS Program
Dallas, Texas
October 15-17, 2009
Hyatt Regency Dallas
Click here for more information

Click here to view past Clinical Update for Ryan White Program



An Intensive Workshop on Antiretroviral Strategies: New Drugs, Antiretroviral Failure, and Resistance Testing
Who should attend: Experienced HIV clinical decision makers with working knowledge of HIV disease management
Click here to view full schedule

General Educational Objectives for
2010 Courses

Upon completion of an IAS-USA course, participants will be able to:

• Design antiretroviral strategies that consider current data on:
  
  • When to initiate therapy
  • new initial regimens
  • Treatment failure and management of complicated failure
  • Mechanisms of resistance and nuances in interpreting resistance test results
  • Drug-drug interactions
  • The role of new and investigational drugs
  • Metabolism complications and toxicities of HIV and its therapies
    
• Identify and discuss new issues in HIV pathogenesis, as they impact clinical treatment strategies
• Formulate appropriate management strategies for HIV coinfection, such as hepatitis B and C viruses and sexually transmitted infections
• Formulate appropriate management strategies for special populations such as substance users, women, and patients with comorbidities
• Discuss topics in HIV clinical treatment specific to the needs of the regional HIV specialists